{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:18:06Z","timestamp":1788517086578,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"DOI":"10.1186\/s43046-026-00406-2","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:57:43Z","timestamp":1788512263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unlocking the potential of bacteriophage-based therapeutic gene delivery in hepatocellular carcinoma"],"prefix":"10.1186","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0183-5442","authenticated-orcid":false,"given":"Sreemoyee","family":"Mitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Damini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreyosi Guha","family":"Niyogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utkarsh Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debanjan","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh Chandra","family":"Bishtania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5857-2624","authenticated-orcid":false,"given":"Shubham","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"issue":"4","key":"406_CR1","first-page":"e70090","volume":"76","author":"H Sung","year":"2026","unstructured":"Sung H, Filho AM, Laversanne M, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. CA: A Cancer. J Clin. 2026;76(4):e70090.","journal-title":"J Clin"},{"issue":"3","key":"406_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.4254\/wjh.v7.i3.362","volume":"7","author":"J Tejeda-Maldonado","year":"2015","unstructured":"Tejeda-Maldonado J, Garcia-Juarez I, Aguirre-Valadez J, Gonzalez-Aguirre A, Vilatoba-Chapa M, Armengol-Alonso A, et al. Diagnosis and treatment of hepatocellular carcinoma: An update. World J Hepatol. 2015;7(3):362\u201376.","journal-title":"World J Hepatol"},{"issue":"6","key":"406_CR3","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.jhep.2019.01.028","volume":"70","author":"JM Llovet","year":"2019","unstructured":"Llovet JM, Montal R, Villanueva A. Randomized trials and endpoints in advanced HCC: role of PFS as a surrogate of survival. J Hepatol. 2019;70(6):1262\u201377.","journal-title":"J Hepatol"},{"issue":"Article10","key":"406_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"J Llovet","year":"2021","unstructured":"Llovet J, Kelley R, Villanueva A, Singal A, Pikarsky E, Roayaie S, et al. Hepatocellular Carcinoma Nat Rev Dis Primers. 2021;7(Article10):6.","journal-title":"Hepatocellular Carcinoma Nat Rev Dis Primers"},{"issue":"1","key":"406_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000546697","volume":"15","author":"YR Kim","year":"2026","unstructured":"Kim YR, Kim E, Kim HI, Han S, An J, Shim JH. Updated network meta-analysis of first-line systemic treatments for advanced HCC: consistent role of TACE. Liver Cancer. 2026;15(1):117\u201334.","journal-title":"Liver Cancer"},{"issue":"7","key":"406_CR6","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3390\/ph14070634","volume":"14","author":"B Gibb","year":"2021","unstructured":"Gibb B, Hyman P, Schneider CL. The many applications of engineered bacteriophages\u2014An overview. Pharmaceuticals. 2021;14(7):634.","journal-title":"Pharmaceuticals"},{"issue":"6","key":"406_CR7","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s12033-024-01195-6","volume":"67","author":"S Jahandar-Lashaki","year":"2025","unstructured":"Jahandar-Lashaki S, Farajnia S, Faraji-Barhagh A, Hosseini Z, Bakhtiyari N, Rahbarnia L. Phage display as a medium for target therapy based drug discovery, review and update. Mol Biotechnol. 2025;67(6):2161\u201384.","journal-title":"Mol Biotechnol"},{"issue":"4","key":"406_CR8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/1574-6976.12006","volume":"37","author":"MJ Catalao","year":"2013","unstructured":"Catalao MJ, Gil F, Moniz-Pereira J, Sao-Jose C, Pimentel M. Diversity in bacterial lysis systems: bacteriophages show the way. FEMS Microbiol Rev. 2013;37(4):554\u201371.","journal-title":"FEMS Microbiol Rev"},{"issue":"7","key":"406_CR9","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3390\/ph14070634","volume":"14","author":"B Gibb","year":"2021","unstructured":"Gibb B, Hyman P, Schneider CL. The Many Applications of Engineered Bacteriophages-An Overview. Pharmaceuticals (Basel). 2021;14(7):634.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"406_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000515304","volume":"10","author":"J Huang","year":"2021","unstructured":"Huang J, Lok V, Ngai CH, Chu C, Patel HK, Thoguluva Chandraseka V, et al. Disease Burden, Risk Factors, and Recent Trends of Liver Cancer: A Global Country-Level Analysis. Liver Cancer. 2021;10(4):330\u201345.","journal-title":"Liver Cancer"},{"key":"406_CR11","doi-asserted-by":"publisher","first-page":"1290296","DOI":"10.3389\/fonc.2023.1290296","volume":"13","author":"MS Islam","year":"2023","unstructured":"Islam MS, Fan J, Pan F. The power of phages: revolutionizing cancer treatment. Front Oncol. 2023;13:1290296.","journal-title":"Front Oncol"},{"issue":"13","key":"406_CR12","doi-asserted-by":"publisher","first-page":"e202200185","DOI":"10.1002\/cmdc.202200185","volume":"17","author":"M Wysocki","year":"2022","unstructured":"Wysocki M, Czarczynska-Goslinska B, Ziental D, Michalak M, Guzel E, Sobotta L. Excited State and Reactive Oxygen Species against Cancer and Pathogens: A Review on Sonodynamic and Sono-Photodynamic Therapy. ChemMedChem. 2022;17(13):e202200185.","journal-title":"ChemMedChem"},{"key":"406_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/978-981-10-8456-0_14","volume":"88","author":"P Tavares","year":"2018","unstructured":"Tavares P. The Bacteriophage Head-to-Tail Interface. Subcell Biochem. 2018;88:305\u201328.","journal-title":"Subcell Biochem"},{"key":"406_CR14","first-page":"19","volume-title":"Structure and function of bacteriophages","author":"M Sanz-Gaitero","year":"2021","unstructured":"Sanz-Gaitero M, Seoane-Blanco M, van Raaij MJ. Structure and function of bacteriophages. Bacteriophages: Biology, technology, therapy: Springer; 2021. pp. 19\u201391."},{"issue":"24","key":"406_CR15","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1002\/1873-3468.13691","volume":"593","author":"J Gao","year":"2019","unstructured":"Gao J, Mese K, Bunz O, Ehrhardt A. State-of-the-art human adenovirus vectorology for therapeutic approaches. FEBS Lett. 2019;593(24):3609\u201322.","journal-title":"FEBS Lett"},{"issue":"10","key":"406_CR16","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1089\/hum.2019.140","volume":"30","author":"N Zabaleta","year":"2019","unstructured":"Zabaleta N, Hommel M, Salas D, Gonzalez-Aseguinolaza G. Genetic-Based Approaches to Inherited Metabolic Liver Diseases. Hum Gene Ther. 2019;30(10):1190\u2013203.","journal-title":"Hum Gene Ther"},{"issue":"4","key":"406_CR17","doi-asserted-by":"publisher","first-page":"100300","DOI":"10.1016\/j.jhepr.2021.100300","volume":"3","author":"S Maestro","year":"2021","unstructured":"Maestro S, Weber ND, Zabaleta N, Aldabe R, Gonzalez-Aseguinolaza G. Novel vectors and approaches for gene therapy in liver diseases. JHEP Rep. 2021;3(4):100300.","journal-title":"JHEP Rep"},{"issue":"24","key":"406_CR18","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1002\/1873-3468.13691","volume":"593","author":"J Gao","year":"2019","unstructured":"Gao J, Mese K, Bunz O, Ehrhardt A. State-of\u2010the\u2010art human adenovirus vectorology for therapeutic approaches. FEBS Lett. 2019;593(24):3609\u201322.","journal-title":"FEBS Lett"},{"issue":"4","key":"406_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1208\/s12248-021-00608-7","volume":"23","author":"H Zu","year":"2021","unstructured":"Zu H, Gao D. Non-viral Vectors in Gene Therapy: Recent Development, Challenges, and Prospects. AAPS J. 2021;23(4):78.","journal-title":"AAPS J"},{"issue":"1","key":"406_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12967-024-05160-4","volume":"22","author":"D Riccardi","year":"2024","unstructured":"Riccardi D, Baldino L, Reverchon E. Liposomes, transfersomes and niosomes: Production methods and their applications in the vaccinal field. J Translational Med. 2024;22(1):339.","journal-title":"J Translational Med"},{"issue":"9","key":"406_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","volume":"23","author":"PR Cullis","year":"2024","unstructured":"Cullis PR, Felgner PL. The 60-year evolution of lipid nanoparticles for nucleic acid delivery. Nat Rev Drug Discov. 2024;23(9):709\u201322.","journal-title":"Nat Rev Drug Discov"},{"issue":"45","key":"406_CR22","doi-asserted-by":"publisher","first-page":"13627","DOI":"10.1021\/acs.langmuir.2c02197","volume":"38","author":"H Ma","year":"2022","unstructured":"Ma H, Cao M. Designed Peptide Assemblies for Efficient Gene Delivery. Langmuir. 2022;38(45):13627\u201334.","journal-title":"Langmuir"},{"issue":"10","key":"406_CR23","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.1007\/s10924-024-03280-y","volume":"32","author":"N Torabi Fard","year":"2024","unstructured":"Torabi Fard N, Ahmad Panahi H, Moniri E, Reza Soltani E, Mahdavijalal M. Stimuli-responsive dendrimers as nanoscale vectors in drug and gene delivery systems: a review study. J Polym Environ. 2024;32(10):4959\u201385.","journal-title":"J Polym Environ"},{"issue":"1","key":"406_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/v7010268","volume":"7","author":"MZI Pranjol","year":"2015","unstructured":"Pranjol MZI, Hajitou A. Bacteriophage-derived vectors for targeted cancer gene therapy. Viruses. 2015;7(1):268\u201384.","journal-title":"Viruses"},{"key":"406_CR25","doi-asserted-by":"publisher","first-page":"14264","DOI":"10.3389\/abp.2025.14264","volume":"72","author":"B Zalewska-Pi\u0105tek","year":"2025","unstructured":"Zalewska-Pi\u0105tek B, Nag\u00f3rka M. Phages as potential life-saving therapeutic option in the treatment of multidrug-resistant urinary tract infections. Acta Biochim Pol. 2025;72:14264.","journal-title":"Acta Biochim Pol"},{"issue":"6","key":"406_CR26","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.tim.2020.10.014","volume":"29","author":"K Bodner","year":"2021","unstructured":"Bodner K, Melkonian AL, Covert MW. The enemy of my enemy: new insights regarding bacteriophage\u2013mammalian cell interactions. Trends Microbiol. 2021;29(6):528\u201341.","journal-title":"Trends Microbiol"},{"issue":"10","key":"406_CR27","doi-asserted-by":"publisher","first-page":"e3002341","DOI":"10.1371\/journal.pbio.3002341","volume":"21","author":"MC Bichet","year":"2023","unstructured":"Bichet MC, Adderley J, Avellaneda-Franco L, Magnin-Bougma I, Torriero-Smith N, Gearing LJ, et al. Mammalian cells internalize bacteriophages and use them as a resource to enhance cellular growth and survival. PLoS Biol. 2023;21(10):e3002341.","journal-title":"PLoS Biol"},{"issue":"10","key":"406_CR28","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.tim.2023.04.008","volume":"31","author":"K Champagne-Jorgensen","year":"2023","unstructured":"Champagne-Jorgensen K, Luong T, Darby T, Roach DR. Immunogenicity of bacteriophages. Trends Microbiol. 2023;31(10):1058\u201371.","journal-title":"Trends Microbiol"},{"issue":"3","key":"406_CR29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0167-4889(98)00162-1","volume":"1448","author":"VV Ivanenkov","year":"1999","unstructured":"Ivanenkov VV, Felici F, Menon AG. Uptake and intracellular fate of phage display vectors in mammalian cells. Biochim et Biophys Acta (BBA)-Molecular Cell Res. 1999;1448(3):450\u201362.","journal-title":"Biochim et Biophys Acta (BBA)-Molecular Cell Res"},{"key":"406_CR30","doi-asserted-by":"publisher","first-page":"109393","DOI":"10.1016\/j.intimp.2022.109393","volume":"113","author":"T Wu","year":"2022","unstructured":"Wu T, Song Z, Huang H, Jakos T, Jiang H, Xie Y, et al. Construction and evaluation of GPC3-targeted immunotoxins as a novel therapeutic modality for hepatocellular carcinoma. Int Immunopharmacol. 2022;113:109393.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"406_CR31","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1021\/acs.bioconjchem.6b00030","volume":"27","author":"D Zhu","year":"2016","unstructured":"Zhu D, Qin Y, Wang J, Zhang L, Zou S, Zhu X, et al. Novel glypican-3-binding peptide for in vivo hepatocellular carcinoma fluorescent imaging. Bioconjug Chem. 2016;27(3):831\u20139.","journal-title":"Bioconjug Chem"},{"issue":"6434","key":"406_CR32","doi-asserted-by":"publisher","first-page":"eaat9691","DOI":"10.1126\/science.aat9691","volume":"363","author":"JM Sweere","year":"2019","unstructured":"Sweere JM, Van Belleghem JD, Ishak H, Bach MS, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363(6434):eaat9691.","journal-title":"Science"},{"issue":"2","key":"406_CR33","doi-asserted-by":"publisher","first-page":"e0171746","DOI":"10.1371\/journal.pone.0171746","volume":"12","author":"C Hulo","year":"2017","unstructured":"Hulo C, Masson P, de Castro E, Auchincloss AH, Foulger R, Poux S, et al. The ins and outs of eukaryotic viruses: Knowledge base and ontology of a viral infection. PLoS ONE. 2017;12(2):e0171746.","journal-title":"PLoS ONE"},{"key":"406_CR34","first-page":"1","volume-title":"Phage Display Technology and the Development of Phage-Based Vaccines","author":"JA Fralick","year":"2020","unstructured":"Fralick JA, Clark J. Phage Display Technology and the Development of Phage-Based Vaccines. Bacteriophages: Springer; 2020. pp. 1\u201338."},{"issue":"5","key":"406_CR35","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1007\/s11033-023-08380-x","volume":"50","author":"HS Pung","year":"2023","unstructured":"Pung HS, Tye GJ, Leow CH, Ng WK, Lai NS. Generation of peptides using phage display technology for cancer diagnosis and molecular imaging. Mol Biol Rep. 2023;50(5):4653\u201364.","journal-title":"Mol Biol Rep"},{"issue":"6","key":"406_CR36","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/biot.201500458","volume":"11","author":"Y Tan","year":"2016","unstructured":"Tan Y, Tian T, Liu W, Zhu Z, C JY. Advance in phage display technology for bioanalysis. Biotechnol J. 2016;11(6):732\u201345.","journal-title":"Biotechnol J"},{"issue":"2","key":"406_CR37","doi-asserted-by":"publisher","first-page":"e6800","DOI":"10.1002\/cam4.6800","volume":"13","author":"H Javid","year":"2024","unstructured":"Javid H, Oryani MA, Rezagholinejad N, Esparham A, Tajaldini M, Karimi-Shahri M. RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin\u2013RGD interactions. Cancer Med. 2024;13(2):e6800.","journal-title":"Cancer Med"},{"issue":"5","key":"406_CR38","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/bios12050342","volume":"12","author":"D Zhao","year":"2022","unstructured":"Zhao D, Cao J, Zhang L, Zhang S, Wu S. Targeted molecular imaging probes based on magnetic resonance imaging for hepatocellular carcinoma diagnosis and treatment. Biosensors. 2022;12(5):342.","journal-title":"Biosensors"},{"issue":"2","key":"406_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41418-022-01059-z","volume":"30","author":"A Montinaro","year":"2023","unstructured":"Montinaro A, Walczak H. Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries. Cell Death Differ. 2023;30(2):237\u201349.","journal-title":"Cell Death Differ"},{"issue":"10","key":"406_CR40","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.3390\/cancers15102752","volume":"15","author":"JM Pimentel","year":"2023","unstructured":"Pimentel JM, Zhou J-Y, Wu GS. The role of TRAIL in apoptosis and immunosurveillance in cancer. Cancers. 2023;15(10):2752.","journal-title":"Cancers"},{"issue":"1","key":"406_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12935-020-01724-8","volume":"21","author":"S Liu","year":"2021","unstructured":"Liu S, Qiu J, He G, He W, Liu C, Cai D, et al. TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3. Cancer Cell Int. 2021;21(1):63.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"406_CR42","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nprot.2007.51","volume":"2","author":"A Hajitou","year":"2007","unstructured":"Hajitou A, Rangel R, Trepel M, Soghomonyan S, Gelovani JG, Alauddin MM, et al. Design and construction of targeted AAVP vectors for mammalian cell transduction. Nat Protoc. 2007;2(3):523\u201331.","journal-title":"Nat Protoc"},{"issue":"3","key":"406_CR43","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nprot.2007.54","volume":"2","author":"B Baudin","year":"2007","unstructured":"Baudin B, Bruneel A, Bosselut N, Vaubourdolle M. A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc. 2007;2(3):481\u20135.","journal-title":"Nat Protoc"},{"issue":"20","key":"406_CR44","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.3390\/cancers14205125","volume":"14","author":"H Alizadeh Zeinabad","year":"2022","unstructured":"Alizadeh Zeinabad H, Szegezdi E. TRAIL in the treatment of cancer: from soluble cytokine to nanosystems. Cancers. 2022;14(20):5125.","journal-title":"Cancers"},{"issue":"5819","key":"406_CR45","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.1138140","volume":"315","author":"R Barrangou","year":"2007","unstructured":"Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 2007;315(5819):1709\u201312.","journal-title":"Science"},{"issue":"1\u20132","key":"406_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cell.2015.12.035","volume":"164","author":"AV Wright","year":"2016","unstructured":"Wright AV, Nunez JK, Doudna JA. Biology and Applications of CRISPR Systems: Harnessing Nature\u2019s Toolbox for Genome Engineering. Cell. 2016;164(1\u20132):29\u201344.","journal-title":"Cell"},{"issue":"1","key":"406_CR47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1146\/annurev-genet-071719-022559","volume":"55","author":"C Liao","year":"2021","unstructured":"Liao C, Beisel CL. The tracrRNA in CRISPR Biology and Technologies. Annu Rev Genet. 2021;55(1):161\u201381.","journal-title":"Annu Rev Genet"},{"issue":"4","key":"406_CR48","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.patbio.2010.01.005","volume":"58","author":"M Kew","year":"2010","unstructured":"Kew M. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris). 2010;58(4):273\u20137.","journal-title":"Pathol Biol (Paris)"},{"issue":"5","key":"406_CR49","doi-asserted-by":"publisher","first-page":"e3015","DOI":"10.1002\/jgm.3015","volume":"20","author":"SL Ginn","year":"2018","unstructured":"Ginn SL, Amaya AK, Alexander IE, Edelstein M, Abedi MR. Gene therapy clinical trials worldwide to 2017: An update. J Gene Med. 2018;20(5):e3015.","journal-title":"J Gene Med"},{"issue":"1","key":"406_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21926\/obm.genet.2401219","volume":"8","author":"M Mittal","year":"2024","unstructured":"Mittal M, Kumari A, Paul B, Varshney A, Saini A, Verma C, et al. Challenges and opportunities of gene therapy in cancer. OBM Genet. 2024;8(1):1\u2013501.","journal-title":"OBM Genet"},{"issue":"6","key":"406_CR51","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/infdis\/jit267","volume":"208","author":"A Fournillier","year":"2013","unstructured":"Fournillier A, Frelin L, Jacquier E, Ahl\u00e9n G, Brass A, Gerossier E, et al. A heterologous prime\/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus. J Infect Dis. 2013;208(6):1008\u201319.","journal-title":"J Infect Dis"},{"issue":"1","key":"406_CR52","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/phe\/phaa003","volume":"13","author":"J Anomaly","year":"2020","unstructured":"Anomaly J. The future of phage: ethical challenges of using phage therapy to treat bacterial infections. Public Health Ethics. 2020;13(1):82\u20138.","journal-title":"Public Health Ethics"},{"issue":"3","key":"406_CR53","doi-asserted-by":"publisher","first-page":"2300355","DOI":"10.1002\/adtp.202300355","volume":"7","author":"D Kang","year":"2024","unstructured":"Kang D, Bagchi D, Chen IA. Pharmacokinetics and biodistribution of phages and their current applications in antimicrobial therapy. Adv Ther. 2024;7(3):2300355.","journal-title":"Adv Ther"},{"key":"406_CR54","doi-asserted-by":"crossref","unstructured":"Tiwari A, Goswami S, Joshi M, Gandhi S, Soni P, Tekade M, et al. PEGylation as a tool to alter immunological properties of nanocarriers. PEGylated Nanocarriers in Medicine and Pharmacy. Springer; 2025. pp. 171\u201393.","DOI":"10.1007\/978-981-97-7316-9_6"},{"issue":"1","key":"406_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12195-026-00888-z","volume":"19","author":"L Abo Qoura","year":"2026","unstructured":"Abo Qoura L, Kostyushev D, Parodi A, Boyarintsev DI, Chulanov V, Pokrovsky VS. Nanoparticle\u2013host interactions: the impact of physiological and pathological factors on biodistribution, immune processes, and translational challenges. Cell Mol Bioeng. 2026;19(1):1\u201327.","journal-title":"Cell Mol Bioeng"},{"key":"406_CR56","doi-asserted-by":"publisher","unstructured":"Manavalan VA, Vinayagam S, Sundaram T, Chopra S, Chopra H, Malik T. Bacteriophage therapy in intensive care units: a targeted strategy to combat multidrug-resistant infections\u2014A. Rev Methodol. 2025;14:100120. https:\/\/doi.org\/10.70389\/PJS.100120.","DOI":"10.70389\/PJS.100120"},{"key":"406_CR57","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/978-3-319-41986-2_25","volume-title":"Bacteriophage manufacturing: From early twentieth-century processes to current GMP","author":"K Regulski","year":"2021","unstructured":"Regulski K, Champion-Arnaud P, Gabard J. Bacteriophage manufacturing: From early twentieth-century processes to current GMP. Bacteriophages: Biology, Technology, Therapy.; 2021. pp. 699\u2013729."},{"issue":"1","key":"406_CR58","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s12967-019-2120-z","volume":"17","author":"Z Cui","year":"2019","unstructured":"Cui Z, Guo X, Feng T, Li L. Exploring the whole standard operating procedure for phage therapy in clinical practice. J Translational Med. 2019;17(1):373.","journal-title":"J Translational Med"},{"issue":"3","key":"406_CR59","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3390\/v15030721","volume":"15","author":"JD Jones","year":"2023","unstructured":"Jones JD, Trippett C, Suleman M, Clokie MR, Clark JR. The future of clinical phage therapy in the United Kingdom. Viruses. 2023;15(3):721.","journal-title":"Viruses"},{"issue":"5","key":"406_CR60","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/jcm9051498","volume":"9","author":"J Yang Zhou","year":"2020","unstructured":"Yang Zhou J, Suwan K, Hajitou A. Initial steps for the development of a phage-mediated gene replacement therapy using CRISPR-Cas9 technology. J Clin Med. 2020;9(5):1498.","journal-title":"J Clin Med"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00406-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00406-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00406-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:02:54Z","timestamp":1788516174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43046-026-00406-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["406"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00406-2","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"69"}}